e.g. mhealth
Search Results (1 to 10 of 12 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 5 JMIR Diabetes
- 3 JMIR Formative Research
- 3 JMIR Research Protocols
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
To date, no interventions on portal adoption have targeted adults with T2 D of diverse races or ethnicities with limited resources, who have unique structural and social barriers to portal access, use, and diabetes self-management.
Community health centers (CHCs) play a critical role in addressing health inequities in T2 D, providing care to over 27 million people in the United States [22].
JMIR Form Res 2025;9:e67293
Download Citation: END BibTex RIS
First-line therapy for the management of type 2 diabetes (T2 D) is lifestyle modification, which includes following evidence-based nutrition and physical activity guidelines [1]. Food choices can play a significant role in achieving glycemic goals and optimizing overall health for people with T2 D [2]. Moreover, continuous glucose monitoring (CGM) has also been shown to improve glycemic outcomes for people with T2 D [3].
JMIR Diabetes 2025;10:e67636
Download Citation: END BibTex RIS
Populations with low income are disproportionately affected by type 2 diabetes (T2 D) [2]. Costs of diabetes related to complications including cardiovascular disease and kidney failure exceed US $7 billion dollars, making diabetes the most expensive chronic condition in the United States [3,4].
JMIR Res Protoc 2024;13:e54043
Download Citation: END BibTex RIS
Analysis of Self-Care Activities in Type 2 Diabetes in Brazil: Protocol for a Scoping Review
DM can be classified into 4 main types, based on its etiology: type 1 diabetes (T1 D), type 2 diabetes (T2 D), gestational DM, and other types of diabetes. T2 D is the most prevalent form, accounting for approximately 90% to 95% of diabetes cases worldwide [2].
The causes of T2 D are still poorly understood, but there is a strong link with excess weight, obesity, lack of physical activity, aging, ethnicity, and family history.
JMIR Res Protoc 2024;13:e49105
Download Citation: END BibTex RIS
Our focus is on type 2 diabetes (T2 D), which is a representative chronic disease condition. T2 D is a high-prevalence, high-burden disease. In the United States, 30 million people are estimated to live with diabetes, the 8th leading cause of mortality [7], and it is estimated to account for over US $300 billion of economic cost [7-9]. The physiologic hallmark of the disease is elevated blood glucose, and success in clinical management is monitored by testing the levels of hemoglobin A1c (Hb A1c) tests [10].
JMIR Diabetes 2024;9:e52688
Download Citation: END BibTex RIS
Chronic conditions such as type 2 diabetes (T2 D) are best treated when the individual living with diabetes is engaged and supported in effective self-management [1,2]. Programs, such as diabetes self-management education (DSME), that promote successful T2 D self-management behaviors can dramatically lower the risk of serious complications [2].
JMIR Form Res 2024;8:e46418
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Type 2 diabetes (T2 D) is one of the most prevalent contemporary public health problems in the United States. If the current trajectory of prevalence continues, 1 in 3 US adults will have T2 D by 2050 [1]. Nutritional management is one of the cornerstones of T2 D treatment, and several dietary approaches are recommended for T2 D, including a very low–carbohydrate (VLC) diet [2].
JMIR Diabetes 2023;8:e44295
Download Citation: END BibTex RIS
Secure Messaging for Diabetes Management: Content Analysis
t2d
JMIR Diabetes 2023;8:e40272
Download Citation: END BibTex RIS
While current guidelines do not address RT-CGM use in patients with T2 D not using insulin, some patients with non–insulin-treated (NIT) T2 D do initiate use of RT-CGM with their physician’s prescription. We sought to further understand this population by analyzing their glycemic metrics, as well as their use of RT-CGM features such as alerts and retrospective data analysis.
JMIR Diabetes 2023;8:e43991
Download Citation: END BibTex RIS